Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone)
Endocrine SocietyThe Endocrine Society, American Association of Clinical Endocrinologists and American Diabetes Association urge diabetes patients to remain on their prescribed medications unless instructed otherwise by their healthcare provider